Help us learn about an investigational formula and it’s health outcomes.

MedPharmics is participating in a study on a new hypoallergenic infant formula for newborns up to 14 days old. In this study, they will evaluate the growth, tolerance and compliance of healthy infants fed a commercially available infant formula compared to those fed the new infant formula. Volunteers who qualify for the study may receive study-related care at no cost, investigational formula at no cost and compensation for time and travel.

MedPharmics is involved in an investigational research trial for a new infant formula.